Bolt Biotherapeutics (BOLT) EPS (Basic) (2020 - 2026)
Bolt Biotherapeutics (BOLT) posted EPS (Basic) of -$4.5 for Q1 2026, down 0.78% sequentially from -$4.47 in Q4 2025, and up 29.87% YoY from -$3.47 in Q1 2025.
Bolt Biotherapeutics (BOLT) EPS (Basic) (2020 - 2026) Analysis & Trends
Bolt Biotherapeutics has reported EPS (Basic) for 7 years, with the latest figure at -$4.5 in Q1 2026.
- Quarterly EPS (Basic) rose 29.87% year-over-year to -$4.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$52.07 (down 40.7% YoY) and the FY2025 annual result came in at -$71.52, up 19.55% from the prior year.
- EPS (Basic) eased to -$4.5 in Q1 2026 per BOLT's latest filing, from -$4.47 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$4.47 in Q4 2025 and troughed at -$31.05 in Q2 2022.
- A 5-year average of -$16.0 and a median of -$11.44 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) soared 66.96% in 2024, then sank 140.13% in 2025.
- Over 5 years, EPS (Basic) stood at -$11.44 in 2022, then jumped by 45.4% to -$6.25 in 2023, then tumbled by 72.21% to -$10.76 in 2024, then surged by 58.49% to -$4.47 in 2025, then dropped by 0.78% to -$4.5 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$4.5, -$4.47, and -$20.88 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Bolt Biotherapeutics | 5.48 Mn | 5.48 Mn | - | -4.85 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.27 |
| Mar 31, 2026 | -4.50 |
| Dec 31, 2025 | -4.47 |
| Sep 30, 2025 | -20.88 |
| Jun 30, 2025 | -22.30 |
| Mar 31, 2025 | -6.42 |
| Dec 31, 2024 | -10.76 |
| Sep 30, 2024 | -8.69 |
| Jun 30, 2024 | -11.24 |
| Mar 31, 2024 | -8.76 |
| Dec 31, 2023 | -6.25 |
| Sep 30, 2023 | -25.76 |
| Jun 30, 2023 | -27.35 |
| Mar 31, 2023 | -26.50 |
| Dec 31, 2022 | -11.44 |
| Sep 30, 2022 | -30.69 |
| Jun 30, 2022 | -31.05 |
| Mar 31, 2022 | -14.91 |
| Dec 31, 2021 | -17.45 |
| Sep 30, 2021 | -33.82 |